These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11365961)

  • 21. FDA notifications. Abacavir approved for pediatric patients.
    AIDS Alert; 2009 Feb; 24(2):21-2. PubMed ID: 19222148
    [No Abstract]   [Full Text] [Related]  

  • 22. Glaxo opens broad expanded access program for abacavir (Ziagen).
    Baker R
    BETA; 1998 Apr; ():6. PubMed ID: 11365271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
    Feigal D
    AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New abacavir data open door to a better treatment paradigm.
    AIDS Alert; 1998 Aug; 13(8):85-7. PubMed ID: 11365647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA notifications. Generic abacavir and lamivudine combo approved.
    AIDS Alert; 2008 Oct; 23(10):115. PubMed ID: 18935685
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA notifications. Abacavir sulfate tablets tentatively approved.
    AIDS Alert; 2011 May; 26(5):59-60. PubMed ID: 21648134
    [No Abstract]   [Full Text] [Related]  

  • 28. Next HIV guidelines likely to include salvage therapy.
    AIDS Alert; 1999 Jul; 14(7):76-8. PubMed ID: 11366417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
    Mascolini M
    AIDS Treat News; 1996 Dec; (No 260):3-5. PubMed ID: 11364022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highlights from the FDA antiviral drug advisory committee meetings, February 27-March 1, 1996.
    Baker R
    BETA; 1996 Mar; ():7-13. PubMed ID: 11363321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What they say about nucleoside drugs.
    Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ziagen OK'd by FDA.
    Gaylord G
    Posit Living; 1999 Feb; 8(1):1, 11. PubMed ID: 12492045
    [No Abstract]   [Full Text] [Related]  

  • 33. The fuss over 1592.
    Vazquez E
    Posit Aware; 1997; 8(5):26-7. PubMed ID: 11364637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drugs: amprenavir and abacavir.
    TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coming therapies: abacavir.
    Staszewski S
    Int J Clin Pract Suppl; 1999 Jun; 103():35-8. PubMed ID: 10622042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA notifications. Ongoing safety review of abacavir, possible MI risk.
    AIDS Alert; 2011 May; 26(5):58-9. PubMed ID: 21649950
    [No Abstract]   [Full Text] [Related]  

  • 37. Delavirdine data: skewed or skewered?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Feb; 3(2):42-6. PubMed ID: 11364099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New expanded access drugs for use in combination therapy.
    Newsline People AIDS Coalit N Y; 1998 Dec; ():22-3. PubMed ID: 11367085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
    AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
    [No Abstract]   [Full Text] [Related]  

  • 40. Two drugs in one pill.
    Vazquez E
    Posit Aware; 1997; 8(6):19. PubMed ID: 11364854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.